YTHDF3 and breast carcinoma: Accumulating evidence has indicated that YTHDF3 promotes tumor progression including breast cancers (17), small-cell lung cancer (SCLC) (18), CRC (19), and other types (20–22); however, the role of YTHDF3 in TNBC is not well understood.